Jesse Lou, MD Anesthesiology - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 19851 Observation Dr Ste 360, Germantown, MD 20876 Phone: 855-527-7246 Fax: 866-229-5063 |
Mr. Kunal Sood, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 19735 Germantown Rd Ste 360, Germantown, MD 20874 Phone: 301-528-2810 |
Kevin Peter Munnelly, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 20201 Century Blvd, Ste 480 Chevy Chase Anesthesia Llc, Germantown, MD 20874 Phone: 301-528-0222 Fax: 301-515-4153 |
News Archive
The announcement at the end of January of the largest coordinated effort to fight neglected tropical diseases (NTDs) provides "more reason to hope that we may soon see a future free of these diseases," Adetokunbo Lucas, former director of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, writes in a Daily Monitor opinion piece.
The Environmental Protection Agency (EPA) just approved two disinfection sprays that can kill severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), on surfaces.
The Associated Press: While President Barack Obama "has set a high priority on battling health care fraud and waste" in Medicare, private contractors are slow in referring cases to law enforcement. "According to congressional investigators, the exact average was 178 days [to refer the case for prosecution].
New evidence-based educational guidelines evaluate the effectiveness of current continuing medical education (CME) practices and provide the first set of recommendations on how those practices need to change in the future.
Professor Matthew Disney of the Department of Chemistry on the Florida campus of The Scripps Research Institute, together with scientists from Mayo Clinic's Florida campus and Johns Hopkins School of Medicine, has been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health to create new RNA-based treatments for the most common form of amyotrophic lateral sclerosis (ALS), as well as a type of frontotemporal dementia (FTD).
› Verified 7 days ago